Aerpio Pharmaceuticals, Inc.
TIE-2 ACTIVATORS TARGETING THE SCHLEMM'S CANAL

Last updated:

Abstract:

Disclosed herein are compounds effective for activation of Tie-2 and inhibition of HPTP-beta. The compounds can provide effective therapy for eye conditions, for example, intraocular pressure, ocular hypertension, and glaucoma.

Status:
Application
Type:

Utility

Filling date:

28 Apr 2020

Issue date:

29 Oct 2020